es acute outcomes after experimental intracerebral hemorrhage. Stroke 2007,38:1621 1625. Ardizzone TD, Lu A, Wagner KR, Tang Y, Ran R, Sharp FR. Glutamate receptor blockade attenuates glucose hypermetabolism in perihematomal Imatinib CGP-57148B brain after experimental intracerebral hemorrhage in rat. Stroke 2004,35:2587 2591. Arguello F, Alexander M, Sterry JA, Tudor G, Smith EM, Kalavar NT, Greene JF Jr. Koss W, Morgan CD, Stinson SF, Siford TJ, Alvord WG, Klabansky RL, Sausville EA. Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity In vivo against human leukemia and lymphoma xenografts. Blood 1998,91:2482 2490. Bain J, McLauchlan H, Elliott M, Cohen P. The specificities of protein kinase inhibitors: an update. Biochem J 2003,371:199 204.
Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P. The selectivity of protein kinase inhibitors: a further update. Fluorouracil Biochem J 2007,408:297 315. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993,7:812 821. Barone FC, Parsons AA. Therapeutic potential of anti inflammatory drugs in focal stroke. Expert Opin Investig Drugs 2000,9:2281 2306. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, Legos JJ, Erhardt JA, Ohlstein EH, Hunter AJ, Harrison DC, Philpott K, Smith BR, Adams JL, Parsons AA. Inhibition of p38 mitogen activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev 2001,21:129 145. Liu et al.
Page 8 Neurobiol Dis. Author manuscript, available in PMC 2011 March 1. NIH PA Author Manuscript NIH PA Author Manuscript NIH PA Author Manuscript Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004,116:281 297. Bartkova J, Zemanova M, Bartek J. Expression of CDK7/CAK in normal and tumor cells of diverse histogenesis, cell cycle position and differentiation. Int J Cancer 1996,66:732 737. Battaglia F, Trinchese F, Liu S, Walter S, Nixon RA, Arancio O. Calpain inhibitors, a treatment for Alzheimer,s disease: position paper. J Mol Neurosci 2003,20:357 362. Berman K, Brodaty H. Tocopherol in Alzheimer,s disease and other neurodegenerative disorders. CNS Drugs 2004,18:807 825. Bhat RV, Budd Haeberlein SL, Avila J. Glycogen synthase kinase 3: a drug target for CNS therapies.
J Neurochem 2004,89:1313 1317. Blagden S, de Bono J. Drugging cell cycle kinases in cancer therapy. Curr Drug Targets 2005,6:325 335. Brandt MD, Storch A. Neurogenesis in the adult brain: from bench to bedside? Fortschr Neurol Psychiatr 2008,76:517 529. Brasnjevic I, Hof PR, Steinbusch HW, Schmitz C. Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases. DNA Repair 2008,7:1087 1097. Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH, Enerly E, Johnsen H, Buganim Y, Solomon H, Goldstein I, Madar S, Goldfinger N, Borresen Dale AL, Ginsberg D, Harris CC, Pilpel Y, Oren M, Rotter V. p53 Repressed miRNAs are involved with E2F in a feed forward loop promoting proliferation.
Mol Syst Biol 2008,4:229. Bueno MJ, de Castro IP, Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle 2008,7:3143 3148. Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer,s disease brain. J Neurosci 1998,18:2801 2807. Caltagarone J, Jing Z, Bowser R. Focal adhesions regulate Abeta signaling and cell death in Alzheimer,s disease. Biochim Biophys Acta 2007,1772:438 445. Carnero A, Hudson JD, Price CM, Beach DH. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol
Related posts:
- Volasertib BI6727 is subject to final editing, composition, and examining
- JAK inhibitor in clinical trials were introduced in 2002 and final results were in acute Ver
- BMS-536924 IGF-1R inhibitor transfected with the EGFRvIII
- ZD4054 186497-07-4 Our findings are in line with the view that, in physiological conditions
- Cilomilast SB-207499 ed compounds is provided in the supplementary material.